47 Per Cent Returns from 52-Week Low; Board Likely to Announce Bonus Shares and Dividend
The stock is up by 47 per cent from its 52-week low of Rs 148.05 per share.
In a forthcoming meeting scheduled for Friday, May 23, 2025, the Board of Directors of Anuh Pharma Limited will convene to consider and approve the audited financial results for the quarter and year ending March 31, 2025, alongside a potential dividend recommendation and a proposal for the issuance of bonus shares, subject to necessary approvals. The agenda also includes reviewing and approving draft audit reports, noting the internal audit report, considering the re-appointment of several Joint Managing Directors and Directors, approving the appointment of a Secretarial Auditor, reviewing the Director’s Report and fixing the date, time, notice, book closure and record date for the Annual General Meeting.
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, download the service details here.
Established in 1960, Anuh Pharma Ltd (APL) is a significant Indian manufacturer and supplier of bulk drugs and chemicals, forming part of the SK Group. The company holds a prominent position as a leading producer of Macrolides and Anti-TB drugs within India, while also maintaining a strong presence in other therapeutic areas such as anti-bacterials, anti-malarial, anti-hypertension and corticosteroids. Notably, APL claims the distinction of being the largest producer of erythromycin salts in India and ranks among the top five globally, additionally holding the title of the world's largest pyrazinamide manufacturer. With marketing collaborations extending to 350 customers across more than 57 countries, including Europe, Mexico and South Africa, Anuh Pharma demonstrates a substantial global reach in the API/bulk drug industry.
The company has a market cap of over Rs 1,000 crore and has delivered good profit growth of 19 per cent CAGR over the last 5 years with a healthy dividend payout of 26 per cent. The stock is up by 47 per cent from its 52-week low of Rs 148.05 per share.
Disclaimer: The article is for informational purposes only and not investment advice.